Article Details

Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program - PR Newswire

Retrieved on: 2022-09-19 10:00:58

Tags for this article:

Click the tags to see associated articles and topics

Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) announced today that its Board of Directors has ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up